Education
About Us
Working with TipRanks
Follow Us
John Sculley Insider Profile
4 Followers
John Sculley, Director at Decoy Therapeutics, holds 1.17M shares in Zeta Global Holdings Corp (Ticker: ZETA), holds 1.00M shares in Celularity (Ticker: CELU), holds 54.40K shares in Decoy Therapeutics (Ticker: DCOY).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-17.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Sculley holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 15, 2021 - Jun 15, 2022
Return:+36.00%
The most profitable trade made by John Sculley
John Sculley's Trading History
Decoy Therapeutics
Jul 12, 2016
Director
Informative Buy
56.13K
$37.05K
Zeta Global Holdings Corp
Apr 03, 2025
Director
Uninformative Buy
24.99K
$19.78M
Celularity
Jun 16, 2023
Director
Uninformative Buy
―
$1.24M
T Mobile US
―
Director
―
$161.19M
List of latest transactions for each holding click on a transaction to see John Sculley's performance on stock
You May Also Like
John Sculley insider profile FAQ
What is the percentage of profitable transactions made by John Sculley?
The percentage of profitable transactions made by John Sculley is 50%.
What is the average return per transaction made by John Sculley?
The average return per transaction made by John Sculley is -17.30%.
What stocks does John Sculley hold?
John Sculley holds: DCOY, ZETA, CELU, TMUS stocks.
What was John Sculley’s latest transaction?
John Sculley latest transaction was an Uninformative Buy of $24.99K.
What was John Sculley's most profitable transaction?
John Sculley’s most profitable transaction was an Informative Sell of ZETA stock on June 15, 2021. The return on the trade was 36.00%.
What is John Sculley's role in Decoy Therapeutics?
John Sculley's role in Decoy Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.